Non-members: Click here to review a complimentary excerpt from "Health Economics & Outcomes Research: Group Structure and Staffing"
Health Outcomes is becoming an integral part of the biopharmaceutical lexicon. Organizations understand that payers and consumers want products that provide positive outcomes for patients' health. One of the key issues facing companies as they establish and expand their Health Outcomes organizations is how to structure and staff these important groups.
To highlight current approaches around Health Outcomes group structure and staffing, Best Practices, LLC conducted a primary research project to inform leaders involved in Health Outcomes operations at biopharmaceutical companies.
This study provides Health Outcomes insights such as:
- The maturity level of Health Outcomes organizations
- The organizational structure and leadership of Health Outcomes organizations
- Resource levels for Health Outcomes groups
This study will inform medical affairs and Health Outcomes leaders on these questions and others regarding the structure and staffing of Health Outcomes groups.
This study contains three segments: all companies, company size and Health Outcomes maturity level.
- Longevity of Health Outcomes Groups
- Health Outcomes Leadership
- Health Outcomes Reporting Structure
- Health Outcomes Group Staffing
SAMPLE KEY FINDINGS
- Length of time a Health Outcomes program has been in place at company
- Title of person who heads the Health Outcomes group
- To what function does the Health Outcomes group report to
- Number of FTEs working in HO group and percentage who are in field-based roles
- Reporting Structure: More than half of the benchmark class companies’ HO groups report to Medical Affairs. Meanwhile, one-fourth of the benchmark class doesn’t have a traditional reporting structure, and report to departments such as global value, access and policy, or market access.
Twenty-three survey responses from Medical Affairs leaders at 23 top life-science companies. Segments were created for all companies, company size and Health Outcomes maturity level. Additional deep-dive interviews were conducted with five selected Medical Affairs executives.